The future of diabetic retinopathy screening
30 April 2020
Spring 2020
Diabetes and its complications account for around 10% of the NHS budget and are projected to swallow up more. Léa Surugue asks what the future holds for national diabetic eye screening.
As many as 4.7 million people in the UK are living with diabetes, of whom 90% have type 2, and one million are undiagnosed (Diabetes UK, 2019). This figure is on the rise in part because of more inactive lifestyles and unhealthier diets.
Until recently in the UK, diabetic retinopathy (DR) and diabetic maculopathy were the leading causes of blindness in the working-age population. However, in 2014, researchers showed that diabetic eye disease had fallen from 17.7% of cases in 2000 to 14.4% in 2010, and concluded that inherited retinal disorders were the new leading cause of blindness in England and Wales (Liew et al, 2014).
Not already a member of the College?
Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
Related further reading
This literature review aims to demonstrate that optometrists are well placed to use this technology in routine practice, in conjunction with measuring systemic BP.
An overview of the background and current treatment options available for the macular diseases retinal vein occlusion, diabetic macular oedema and age-related macular degeneration.
The Clinical Management Guidelines (CMGs) set out the evidence to inform your clinical practice and support professional judgement with respect to diagnosis and management.